The Cambridge drugmaker (Nasdaq: MRNA) is using some of the billions of dollars it's been sitting on to acquire a Japanese DNA supplier in a $85 million deal.
The Cambridge drugmaker (Nasdaq: MRNA) is using some of the billions of dollars it's been sitting on to acquire a Japanese DNA supplier in a $85 million deal.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.